最后更新
2018年9月16日
干细胞创新(SCI)是一个由积极性高的研究人员,专业医疗专业人士,专业投资者和创新工程师组成的网络,共同创造一个独特的平台,汇集了21世纪最具改变生命的两项创新:干细胞技术和区块链te chnology。
自2013年初以Camden RAD,LLC的名义成立以来,SCI在世界各地的干细胞研究和开发中发挥了至关重要的作用,我们已经开展了自己的国内和国际案例研究,以进一步推动这一令人兴奋的领域的研究。 。 SCI在干细胞科学领域的活动直接促进了该领域的进步,以及世界各地新的干细胞发现。
干细胞是在人体中发现的独特类型的多细胞。它是一种无差别的细胞集合,能够为新细胞的开发提供无数应用,用于治疗疾病和病症,恢复和恢复身体部位,以及我们的研究和开发,还有更多的应用。
迄今为止,SCI的研究领域包括矫形,神经和肺部疾病以及肿瘤干细胞应用。虽然SCI进行的研究在这些医学领域取得了长足进步,但仍有
目前,美国和世界各地的医院和组织正在开展干细胞研究以推动该领域的发展。迄今为止,大多数案例研究都显示出积极的发现。在美国以外的临床研究期间,干细胞已成功用作治疗形式。干细胞治疗和技术仍然处于医学研究和发现的最前沿,我们预测干细胞将成为医学界更重要的一部分。
除了进一步研究外,SCI还计划通过其干细胞应用生态系统提供干细胞库。通过一个安全的应用程序,父母将能够订购收集套件,安排快递取件,并注册干细胞储存。因为SCI将为其用户提供全球干细胞储存和治疗选择网络,它的独特定位是简化父母的干细胞保存过程,降低收集和储存成本。
SCI开发了一种独特的配方,使我们的用户可以根据自己的医疗需求购买独特的,定制的合成干细胞治疗。通过患者的同意和最少的信息,如出生日期,血型,过敏,诊断和一些健康相关的问题,SCI将运行内部,安全的实验室序列,插入我们开发的专有算法。该算法使得能够为需要特定治疗的个体构建定制设计的合成干细胞。 SCI为这项突破性的技术感到自豪,并且更加兴奋地与全世界分享。干细胞研究和SCI可及性的进步将引领世界为生命做出杰出的创新。 
Protecting confidential user information is vital to the success of a system like the one we are proposing. to ensure security and privacy, Stem Cell Innovations will require users signing into the SCIApplication to provide information and generate a unique identifier within the SCI ecosystem. A unique identifier is an alphanumeric string of information that is assigned to a specific piece of data in an electronic database; in this case, the SCI platform and application. users will be given a unique identifier that will be generated using a proprietary algorithm, which will be used and stored using blockchain technology. the SCI unique identifier will act as users’ keys within the SCI network. through cryptographic methods, the data used to generate the key will be kept secret and secure, able to be parsed only by the SCI decoder. unique identifiers enable access to customized stem cell services and therapies offered throughout the expansive SCI network to our users. SCI will provide personalized stem cell solutions to patients using our platform, and as the SCI network and suite of services grow, users who opt into these services will be apprised of advancements and new treatment options as they become available.
SCI plans to run on dual blockchain platforms. the first platform will be built on an ethereum base for token use only, and it will be powered by the eRC20 platform. the second blockchain will be a custom application designed and built by SCI engineers tailored to fit the healthcare environment.
SCI has decided to build its own blockchain for storing and processing patient stem cell records. this customized blockchain is known as SCIChain. SCIChain will use the Hyperledger fabric network, which will be designed to use smart contracts to protect data and ensure only authorized individuals have access to user data. SCI engineers realize that the Hyperledger fabric blockchain has unique functionalities that differ from other blockchain types that fit with the needs of SCI’s vision and product.
Smart contracts are the gatekeepers of the SCIApplication. users will be free to change their settings at will should their treatments change or preferences change. using mathematical equations equal to the eRC20 platform, SCI ensures user privacy. the straightforward validation associated with a blockchain environment is a secure process that ensures data integrity. furthermore, a cryptography public key will be added to the SCIChain and application to promote a higher standard of security. the symmetric-encrypted key used by SCIChain is 2048-bit, which is a supremely secure method of data transformation in today’s technology-based world.
white_paper_v1.1.pdf
验证 86%
注意。未经证实的成员实际上可能不是团队成员
此优惠仅基于要约人提供的信息及其他公开信息。令牌销售或交换活动与ICO持有人完全无关,ICO持有人不参与(包括任何技术支持或促销)。仅显示ICO持有人无关的人员列出的令牌销售仅用于帮助客户跟踪总体令牌部门内发生的活动。这些信息并不意味着相当于您应该依赖的建议。在采取或不采取任何行动之前,您必须获得专业或专家的建议或进行自己的尽职调查。贡献者就收购令牌所订立的任何条款及条件属于其之间,而令牌及ICO持有人的发行人并非该等令牌的卖方。对于任何代币销售而言,ICOholder对第三方所作的任何陈述不承担任何法律责任,并且还必须直接针对此处列出的代币发行实体提出任何违反合同的请求。
如果您有任何疑问关于此令牌销售的性质,合法性或合法性或相关人员,请联系info@icoholder.com,了解有关您的疑虑的详细信息。